Check 35,000+ stocks against 26 valuation models and 37 quality factors

Muenchener Rueckver Ges (MURGY) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Muenchener Rueckver Ges $8.00, price $11.37, upside -29.7%, quality 44 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? No
Good quality? No
Add to watchlist

Financial Services · US · ISIN US6261881063

Broad data Sep 23, 2026

Muenchener Rueckver Ges

MURGY · US

Weak valuationQuality is weak on top of the rich price.

!Fair value $8.00 · Overvalued (−30%)

!Quality 44/100

!Expensive Growth (revenue 5y +2.6 %/yr)

✓Solidly profitable · 11.0% net margin (TTM)

✓Low debt · generates free cash flow

·5.29% dividend yield

!Mixed vs. peers (6/15)

✓Wide moat 67/100

26 models, one by oneBear $6.23 to bull $10.90 Growth analysisrevenue history, year by year Quality 44/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Muenchener Rueckver Ges for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $3.69 – $13.48 · fair‑value band $6.23 – $10.90 · the $11.37 price screens above the $8.00 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Muenchener Rueckver Ges in your weekly email

Every Wednesday you see whether Muenchener Rueckver Ges is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Münchener Rückversicherungs-Gesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through six segments: Life and Health Reinsurance, Property-Casualty Reinsurance, Global Specialty Insurance, ERGO Life and Health Germany, ERGO Property-Casualty Germany, and ERGO International. The company offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, data analytics, underwriting and claims, medical research, capital management, and health market, as well as MIRA digital suite that includes MIRA PoS, MIRApply insured and physician, claims risk assessment, and CLARA plus. It also provides property and casualty reinsurance solutions, including agricultural reinsurance; business advisory, personal lines, portfolio management, insurance consulting, commercial motor consulting; infrastructure risk; property insurance, location risk, insurance linked securities, and NatCatSERVICE for natural catastrophe loss database; prospective structured and retroactive reinsurance; risk transfer; cyber; and data analytics, REALYTIX ZERO, and cert2go. In addition, the company offers solutions for industry clients, such as corporate risk, new tech, green tech, parametric, and aviation and space solutions, as well as risk services. Further, it provides specialty property casualty insurance, such as professional liability, marine, cyber, aviation, and space for commercial and private customers. Additionally, the company offers life, property-casualty, health, legal protection, and travel insurance products under the ERGO brand; and insurance solutions for agriculture, captive, epidemic, cyber, and renewable energy sectors. The company was founded in 1880 and is based in Munich, Germany.

Stock analysis

Muenchener Rueckver Ges (MURGY) currently trades at $11.37, while our model-based Fair Value estimate is $8.00, implying the stock looks roughly 42.1% overvalued today.

Valuation

Bull case: the Economic Profit group reads highest at a median of $7.67 per share, and 1 of the 6 models we run sit above the $11.37 price.

Bear case: the Asset-Based group reads lowest at $3.48, and 5 of the 6 models stay below the price. Evidence for this calculation is high.

Scenario range: $6.23 (bear) to $10.90 (bull), the price of $11.37 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Financial Services sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Muenchener Rueckver Ges reported revenue of €66.6B in FY2025 versus €63.9B in FY2021, a compound +1.0%/yr. Reported net income was €5.9B in FY2025, compounding +19.0%/yr from FY2021.

Key figures

Market cap $73.8B · P/E ratio 9.4 · P/S ratio 0.83 · EPS (TTM) $1.21 · Dividend yield 5.3% · Net margin 8.8% · Return on equity 19.9% · Return on assets (EBIT) 2.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (medium confidence).

What moves the price

The share trades about 11% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at 24% fair-value upside, at −30%, MURGY screens richer than that median.

Fair Value models

Bear $6.23 Fair Value $8.00 Bull $10.90

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

Gordon GGM $3.60 $4.66 $5.74 69

DDM Multi-Stage $3.60 $4.90 $6.48 67

Residual Income $5.97 $7.67 $22.45 66

All 6 models by family

Dividend Discount

Gordon GGM $3.60 $4.66 $5.74 69

DDM Multi-Stage $3.60 $4.90 $6.48 67

Multiples

P/E Multiple $8.96 $11.94 $14.93 63

P/B Multiple $5.45 $7.27 $9.09 55

Asset-Based

NCAV (Graham) $2.60 $3.48 $5.19 54

Economic Profit

Residual Income $5.97 $7.67 $22.45 66

Open the full fair value analysis →

Notify me when MURGY reaches fair value

Put MURGY on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 44/100

Of which business quality 33 · Market factors (momentum, volatility) 56

Profitability 38

Margins and returns on capital today

Quality Growth 53

Are margins and returns improving?

Cashflow 32

Earnings quality: real cash, not paper profit

Fin. Strength 7

Balance sheet, leverage, solvency risk

Investment 88

Disciplined investing over empire-building

Low Volatility 92

Calm price path (market factor)

Momentum 43

Price trend over the last 3–12 months (market factor)

52W Momentum 39

Distance to the 52-week high (market factor)

Net Issuance 0

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 53/100

The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Revenue growth 1 year

+57.3%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+18.8%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+2.6%

Start year 2020 (pandemic). Over 10 years: +1.7% a year

Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+1.7%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.

−8.4%

Earnings growth per share plus dividend.

Earnings per share, growth per year−13.7%

Dividend (yield on the price)5.3%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−14% vs −7%, slowing

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 12%

Start year 2020 (pandemic)

⚠ Revenue per share shrinking 1.1%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Growth Forecast

A lot of optimism in the price

The price assumes more growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+26.0%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+3.7%

Yearly sales growth analysts expect, extended to five years.

After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +23.3% a year for the price and +1.5% for the forecasts.

Forecast 2026 (sales)+5.0%

Forecast 2027 (sales)+3.7%

Projected 2028 (sales)+3.4%

Projected 2029 (sales)+3.2%

Projected 2030 (sales)+3.0%

MURGY screens 42% overvalued. Compare with MUV2 →

Compare Muenchener Rueckver Ges with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Reinsurance · 28 stocks

Beats the industry median on 6/15 measures

A mixed picture versus its industry peers.

Valuation

Quality Score 38 · Bottom 25%

Fair Value upside −30% · Bottom 25%

Profitability

Return on equity (TTM) 20% · Above median

Return on assets 2% · Below median

Net margin (TTM) 11% · Below median

Operating margin (TTM) 15% · Above median

Growth and dividend

Revenue growth −6% · Below median

Dividend yield (TTM) 5.3% · Above median

Balance sheet

Debt / equity 0.22× · Below median

Valuation Multiplesvs Insurance - Reinsurance median · lower = cheaper

P/E (TTM) 9.4× · Cheaper than median

P/B 2.22× · Priciest 25%

P/S (TTM) 1.20× · Pricier than median

P/FCF 69.5× · Priciest 25%

EV/EBITDA 10.4× · Priciest 25%

PEG 1.93× · Cheaper than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 47

FUTURE (revenue growth)0 · sector 0

PAST (return on equity)79 · sector 57

HEALTH (low debt)89 · sector 89

DIVIDEND (yield)100 · sector 94

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Insurance - Reinsurance stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
MUV2 MUV2	€501.80	€433.82	−14%
Swiss Re AG SREN	CHF 138.55	CHF 123.74	−11%
Hannover Rück SE HNR1	€252.60	€207.39	−18%
Reinsurance Group RGA	$245.82	$198.02	−19%
Everest Group EG	$370.96	$410.85	+11%
RenaissanceRe Holdings RNR	$325.90	$563.91	+73%
General Insurance Corporation GICRE	₹344.15	₹427.20	+24%
SCOR SE SCR	€32.16	€39.93	+24%
China Reinsurance (Group) Corporation 1508	HK$1.21	HK$2.42	+100%
Hamilton Insurance Group HG	$33.74	$52.40	+55%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Muenchener Rueckver Ges · Fair Value
$8.00 −42%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/MURGY" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Muenchener Rueckver Ges · Fair Value</span><br><b style="font-size:20px">$8.00</b> <span style="color:#e0816f;font-weight:700;font-size:14px">−42%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Muenchener Rueckver Ges Fair Value". https://www.fairvalue-calculator.com/stock/MURGY

Frequently asked questions

Is Muenchener Rueckver Ges (MURGY) overvalued or undervalued?

As of Sep 23, 2026, our model estimates a fair value of $8.00 versus a price of $11.37, about −30% upside (overvalued).

What is the fair value of MURGY?

Our model-based fair value for Muenchener Rueckver Ges is $8.00 (as of Sep 23, 2026), built from audited fundamentals. The current price: $11.37.

What is the quality score of MURGY?

Muenchener Rueckver Ges has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Muenchener Rueckver Ges (MURGY)?

Our model-based price target is the fair value of $8.00 (as of Sep 23, 2026) from 6 valuation models. Cautious scenario $6.23, optimistic scenario $10.90. It is a calculation from audited fundamentals, not an analyst target.

What is the Muenchener Rueckver Ges stock forecast for 2026?

Our models put fair value at $8.00, about −30% upside versus a price of $11.37 (overvalued). Cautious scenario $6.23, optimistic scenario $10.90. The calculation is refreshed regularly with new filings.

What is the revenue of Muenchener Rueckver Ges (MURGY)?

Muenchener Rueckver Ges reported trailing-twelve-month revenue of about €61.4B (latest available figure, as of Sep 23, 2026).

Does Muenchener Rueckver Ges pay a dividend?

Muenchener Rueckver Ges currently shows a dividend yield of about 5.29% relative to its recent price (as of Sep 23, 2026).

What growth is priced into Muenchener Rueckver Ges (MURGY)?

For today's price to be fair in a discounted-cash-flow model, Muenchener Rueckver Ges would have to grow free cash flow by +26.0 % per year for five years (discount rate 8.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.6 % per year. As of Sep 23, 2026.

What discount rate (WACC) does the fair value of MURGY use?

Our models discount Muenchener Rueckver Ges at 8.1 %: a base by market capitalisation (large), damped by beta 0.34, country premium for USA. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Muenchener Rueckver Ges that is +26.0 % per year a year over ten years, using the same discount rate (8.1 %) and the same formula as our fair value.

How much growth has Muenchener Rueckver Ges (MURGY) delivered so far?

Over the past 5 years revenue at Muenchener Rueckver Ges grew +2.6 % a year. The price currently implies +26.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Muenchener Rueckver Ges (MURGY) growing?

The median revenue growth in the sector is +8.4 % a year. That is the yardstick for the growth priced into Muenchener Rueckver Ges (+26.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Muenchener Rueckver Ges (MURGY)?

The free-cash-flow yield on the price is 1.64 %: that much free cash flow Muenchener Rueckver Ges produces per unit of market value. When it exceeds the discount rate of our models (8.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Muenchener Rueckver Ges (MURGY)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Muenchener Rueckver Ges it is $8.00 per share (as of Sep 23, 2026), against a price of $11.37. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).

Is Muenchener Rueckver Ges stock overvalued or undervalued in 2026?

As of Sep 23, 2026, MURGY trades above its calculated fair value: price $11.37, fair value $8.00, a gap of about −30% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of MURGY?

No. The price is what the market pays today ($11.37); the fair value is what the company's own numbers justify ($8.00). For Muenchener Rueckver Ges the two are $3.37 per share apart. That gap is exactly why we show both numbers side by side.

How much is Muenchener Rueckver Ges worth?

The market values Muenchener Rueckver Ges at about $73.8B (market capitalisation, as of Sep 23, 2026). Per share that is $11.37; our models calculate a fair value of $8.00 per share.

What do the bullish and bearish scenarios say about MURGY?

Our models span a range for Muenchener Rueckver Ges: cautious scenario $6.23, base $8.00, optimistic $10.90 per share (as of Sep 23, 2026, price $11.37). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of MURGY?

Muenchener Rueckver Ges trades at a price-to-earnings ratio of 9.4 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $8.00 is built from several models across several years. Other multiples: PEG 1.9, P/B 2.2, P/S 1.2, EV/EBITDA 10.4.

What is the PEG ratio of MURGY?

The PEG ratio of Muenchener Rueckver Ges is 1.93 (P/E divided by earnings growth, as of Sep 23, 2026). That is above 1, so the growth is already paid for in the price.

How solid is the balance sheet of Muenchener Rueckver Ges (MURGY)?

Balance-sheet figures for Muenchener Rueckver Ges (as of Sep 23, 2026): return on equity 19.9%, debt of 0.22 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.

How far is MURGY from its 52-week high?

Muenchener Rueckver Ges trades at $11.37, about 11% below its 52-week high of $12.74 and 12% above the low of $10.11 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $8.00 is for.

Which stocks are comparable to Muenchener Rueckver Ges?

From the same area (Financial Services) we also value MUV2, Swiss Re AG, Hannover Rück SE, Reinsurance Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Muenchener Rueckver Ges stock attractive at the current price?

The data as of Sep 23, 2026: price $11.37, calculated fair value $8.00 (−30%), Quality Score 44/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of MURGY calculated?

We run Muenchener Rueckver Ges through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $8.00, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.1 % above its aggregate fair value. Muenchener Rueckver Ges itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Muenchener Rueckver Ges (MURGY)?

The closing price on Sep 23, 2026 was $11.37. Our model-based fair value is $8.00, about −30% upside (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Muenchener Rueckver Ges right now?

The price sits above even our optimistic bull case ($10.90). The favourable scenario is already priced in. Weak quality (44/100) and above fair value at the same time, the margin of safety is missing on both counts. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Where does the earnings growth of Muenchener Rueckver Ges (MURGY) come from?

Earnings per share at Muenchener Rueckver Ges grew −0.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share −7.9 %, EBIT margin +10.3 %, tax rate −2.1 %, residual (interest, one-offs) +0.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Muenchener Rueckver Ges

How large is the market capitalisation of Muenchener Rueckver Ges (MURGY)?

The market capitalisation of Muenchener Rueckver Ges is $73.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Muenchener Rueckver Ges (MURGY)?

The price-to-sales ratio of Muenchener Rueckver Ges is 0.83 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Muenchener Rueckver Ges (MURGY)?

Earnings per share at Muenchener Rueckver Ges are $1.21 (price ÷ EPS = P/E 9.4). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Muenchener Rueckver Ges (MURGY)?

The dividend yield of Muenchener Rueckver Ges is 5.3% (payout 49.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Muenchener Rueckver Ges (MURGY)?

The net margin of Muenchener Rueckver Ges is 8.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Muenchener Rueckver Ges (MURGY)?

The return on equity (ROE) of Muenchener Rueckver Ges is 19.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Muenchener Rueckver Ges (MURGY)?

On an EBIT basis the return on assets of Muenchener Rueckver Ges is 2.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Muenchener Rueckver Ges (MURGY)?

The operating margin of Muenchener Rueckver Ges is 15.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Muenchener Rueckver Ges (MURGY)?

Revenue at Muenchener Rueckver Ges is growing −6.0% versus a year earlier (3y avg +18.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Muenchener Rueckver Ges (MURGY)?

Earnings per share at Muenchener Rueckver Ges are growing +60.8% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net debt does Muenchener Rueckver Ges (MURGY) carry?

The net debt of Muenchener Rueckver Ges is €1.9B (fiscal year 2025, ≈ 1.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Muenchener Rueckver Ges in the live analysis

One click puts Muenchener Rueckver Ges on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.